Where medication may fit
Semaglutide and tirzepatide may be considered for eligible patients using the appropriate product and indication.
They act on hormone pathways involved in appetite and blood-sugar regulation; tirzepatide acts on both GIP and GLP-1 receptors. The choice depends on your health history and the clinician's assessment.












